DiabetesMine Innovation Summit Unveils New Tech & Products for Type 1 Diabetes
There is one common goal in the diabetes healthcare industry: we want to make life with type 1 diabetes (T1D)…
The Evolving Promise of Continuous Glucose Monitors
Continuous glucose monitors (CGMs) are becoming an increasingly popular tool for people with diabetes. Combined, there are roughly 5 million…
New Research Opportunity Coming Soon: T1D Exchange Registry + Big Data
Recently, we published an article titled “Data From Your CGM Could Help Change the Future of T1D Care” which provided…
Data from Your CGM Could Help Change the Future of T1D Care
T1D Exchange is focused on using real-world research to change and improve the healthcare provided to people with type 1…
Latest News on Beta Bionics’s iLet – Interview with interim CEO, Martha Goldberg Aronson
T1D Exchange was recently offered an opportunity to interview Martha Goldberg Aronson, the interim CEO of Beta Bionics. Beta Bionics…
Status Update: Automated Insulin Delivery Devices
The holy grail of insulin delivery for people with diabetes who use insulin is an automated insulin delivery system (AID)…
Digitizing Diabetes Management with T1D Apps
If you’ve lived with type 1 diabetes (T1D) for a long time, you’ve probably noticed how over the years, more…
Meet the Expert: Using Diabetes Tech to Improve Patient Care
Priya Prahalad, MD, PhD, is a Clinical Associate Professor of Pediatrics and Medical Director of Clinical Informatics at Stanford Children’s…
Status Update: Connected Insulin Delivery Devices
Do these stats surprise you? Of the 1.6 million people with type 1 diabetes in the US,1 only 30 to…
A Guide to CGMs and Medicaid Coverage Differences by State
Continuous Glucose Monitors (CGMs), the small devices that many people with diabetes wear on their bodies, are incredible tools for…